EVOPEDIA

← all systems · see it in The System

Advocacy group (interest group)

Advocacy groups (also lobby groups, interest groups, special interest groups, pressure groups) are organised groups that use various forms of advocacy or lobbying to influence public opinion and ultimately public policy.

Properties published scienceour proposal

Sourced fields, and our own readings.

aliasesInterest group
born atbooked: 1769 (Society for the Supporters of the Bill of Rights); factions and guilds older (contested)
born precisionyear
boundaryInside: one organised group pressing a shared interest or cause on public policy and opinion: its members and supporters, its leaders, board and staff, its in-house lobbyists, its money and expertise, its positions and its cause. Outside: the people and firms whose stakes it claims to carry (including the non-members who benefit anyway), the policymakers it targets (legislators, bureaucrats, judges, parties), rival and allied groups (together the interest group population of a polity), hired lobbying firms, the media and public it campaigns in, and the laws that register, tax and regulate it.
nested levelBuilt from people (members, activists, staff, lobbyists); one of the organisations of a human society and of its civil society; groups together make the interest group population (pressure system) of a polity. Carried by people (human L6-L7: interests, values, identity, joining and paying).
scalesocial

Measures (23) published science

Swiss MPs' interest-group board ties (2000-2015)524 MPs, 6342 ties, 23,750 instruments; 6.15 boards per MP count
effect of one more formal tie on instruments in that policy areaIRR 1.109 (party and voter controls), 1.075 (with occupation and committee) incidence rate ratio
decay of a tie's effect after it endsgone at the latest 2 years after the tie ends
lobbying synchronised with the electoral cycle (US)block structure in target correlations that follows the election cycle
LDA reporting periodquarterly filings period
US federal lobbying spend 2025$4,374,369,275 (health $867.5 million first; ideological/single-issue $238.9 million) USD
US federal lobbying spend 1998 and 2010$1.4 billion and $3.5 billion USD
registered Washington lobbyists 201312,281 (estimated working lobbyists close to 100,000) people
harmful-industry lobbying spend 1998-2020$3.26 billion of $56.7 billion (5.7%); UPF $1.15 billion, gambling $817 million, tobacco $755 million, alcohol $541 million USD (2020)
lobbyists with government backgrounds (top-16 harmful-industry clients)62% former government employees, 3% former members of Congress; 71% of third-party vs 35% of in-house
tobacco lobbying concentrationtwo clients over 60% (Altria 31%, Philip Morris International 29%)
former members of Congress registering to lobby (1998-2005)43% of 198
citizens' perception of lobbyingCanada: 28.7% danger, 32.1% neutral, 39.2% beneficial (n=3946); Switzerland: 58.1% danger, 29.7% neutral, 12.1% beneficial (n=1651)
online lobbyist registers28 countries of 128 surveyed; none meets all 50 FOCAL indicators; PMI or BAT lobbying visible in 14 of 28
FDA advisory committee meetings with an industry-tied patient or consumer representative (2013-2022)38%; over 50% on several committees; 11% tied to the sponsor of the drug under review
undisclosed affiliations among affiliated patient representatives89.5% (51 of 57)
public-opinion responsiveness in the vignette experiment55% chance of favouring with 55% voter support, 3 points above the 45% scenario; 2000+ Danish and Dutch representatives
US sugar quota: jobs and welfare cost2,261 jobs; $1.162 billion welfare loss; over $500,000 per job USD
police collective bargainingrights in 41 states and D.C.; about 18,000 police departments; FOP about 354,000 members count
bill positions dataset279k positions of 12k interest groups on 42k bills (111th-117th Congresses) count
lobbied-bill prediction78% accuracy (ROC AUC above 0.85); 88% accuracy (95% ROC AUC) for higher-intensity lobbying
Greenpeace offices and incomeoffices in over 30 countries; $50 million a year count/USD
age of the first sustained advocacy group1769 (Society for the Supporters of the Bill of Rights) to 2026: about 257 years

Open contentions (5) open contention

Where sources or readings disagree. Both stay on the map.

Partners and parts published science

Built from / builds (10)

Sits inside / holds (4)

Trades with (valence) (15)

expressed by (15)

floor filled by (14)

Kinds (17)

Notes published science

Layers

The ways it takes in its world, where they meet, and how it acts back, each from L1 (where it meets the world) up.

advocacy group: society's interests to policy and opinion (reader's view)

  1. L1: Interests in society: people, firms and sectors with a stake in public policy, most of them unorganised (latent groups); motives political, economic, religious, moral, commercial or common-good
  2. L2: Mobilisation: joining and paying against the free-rider problem; selective (members-only), solidarity and expressive incentives; patrons, grants and sponsors
  3. L3: Organisation and resources: leaders, board and staff, in-house lobbyists or hired lobbying firms, money and expertise, coalitions
  4. L4: Monitoring and positions: watching bills, regulations and courts; positions taken on each bill (support, oppose, amend, monitor); research, polls and policy briefings
  5. L5: Strategy and access: choosing venue (bureaucracy, legislature, courts, parties, media) and mode (inside or outside lobbying, fast or slow); insider or outsider status
  6. L6: The cause and its claim: the interest or value pressed, framed as public interest or representative claim; the group's legitimacy and reputation
  7. L7: Influence on policy and opinion: policymakers' votes, rules and rulings moved (or not), public opinion shifted, standing access won; at the extreme, capture

the boardroom (shared floors)

  1. L5: Leaders, board and staff deciding venue and mode: bureaucracy, legislature, courts, parties or media; inside or outside lobbying; fast or slow
  2. L6: The cause and its claim: the interest or value pressed, framed as public interest; the group's legitimacy (diffuse interests' legitimacy premium)
  3. L7: Influence on policy and opinion: the group's whole effect on what policymakers decide and what the public thinks

way in: Access to policymakers

  1. L1: Policymakers who decide: legislators, regulators in the executive, sometimes judges
  2. L2: Points of contact: meetings, hearings, consultations, board seats held by legislators (6342 ties of 524 Swiss MPs)
  3. L3: The exchange: information as a legislative subsidy, money and electoral support for attention; reciprocity, instrumental and symbolic
  4. L4: Policymakers' responses read back: activity in the group's policy area, intended votes (strong for public opinion, weaker for groups, aligned legislators most)

way in: Courts and rulings

  1. L1: Disputes and constitutional questions the group can bring or join; where courts can review legislation, groups gain more
  2. L2: Cases funded or joined: legal defence funds and amicus curiae briefs
  3. L3: Rulings read back (the 1954 school-segregation ruling after NAACP pressure)

way in: Law and regulation of groups

  1. L1: Laws that empower or bind groups: collective bargaining laws (police unions in 41 states), tax status, lobbying law
  2. L2: Registration and disclosure: lobby registers (online in 28 countries, none complete)
  3. L3: Compliance and its penalties

way in: Members and supporters

  1. L1: People (or firms) sharing a stake in a policy, a latent group until organised; the larger the group, the stronger the pull to free ride
  2. L2: The joining decision: why join if the benefit comes anyway; selective, solidarity and expressive incentives; a critical mass of early contributors
  3. L3: Dues, donations and volunteered time pooled
  4. L4: The membership roll and the resource base the leaders read: a continuing supply to secure

way in: Patrons, sponsors and grants

  1. L1: Outside funders: supportive constituencies, membership fees, national funding and grants; firms funding allied groups (the drug industry funding patient groups)
  2. L2: Grants and sponsorships received; resource dependence: the fit between resources and context shapes success
  3. L3: The funder's ties carried into the group and on into public bodies: industry-funded advocacy groups placing representatives on FDA committees

way in: Public opinion and media

  1. L1: The public and its views on the issue and on lobbying itself
  2. L2: Media coverage and social media: Facebook and Twitter used by nearly all of 53 US groups surveyed (2012)
  3. L3: How citizens see lobbying: a danger or a benefit to democracy, shaped by regulation and trust
  4. L4: The opinion climate the group reads, including its own polls and research

way in: Rival and allied groups

  1. L1: Competing groups on the same issue, often with very different resources (Tobacco Institute against Action on Smoking and Health)
  2. L2: The density of the group population in a system
  3. L3: Competition for access: more groups, more competition
  4. L4: The group's standing in the population: an established player or one of a rotating many; coalitions with heterogeneous allies to signal consensus

way in: The policy agenda

  1. L1: The stream of bills, regulations and decisions; when the legislature stalls, lobbying dips
  2. L2: Disclosed filings and the legislative record read by groups and about groups; US activity synchronised with electoral cycles
  3. L3: Monitoring by issue area: groups active across several issue areas (Indian environmental groups, European business associations)
  4. L4: A position on each bill: support, oppose, amend or monitor; positions follow the bill through its stages

way in: Watching government and firms

  1. L1: The actions of governments and corporations a watchdog follows
  2. L2: Records and datasets gathered, mostly by NGOs (revolving-door records: 41 found, 17 Australian, 10 UK, 14 US)
  3. L3: Indexing and rating in databases
  4. L4: The rating or report the group issues from

way out: Campaign money, endorsements and election advertising

  1. L1: Candidates elected or unseated; parties funded or founded
  2. L3: Campaign finance and election advertising (the US Chamber of Commerce's ads against a Mississippi justice)
  3. L5: Choosing to act on elections and parties

way out: Inside (direct) lobbying

  1. L1: Decisions moved: bills, rules, and regulators' rulings (lobbying firms got milder FDA recall classifications)
  2. L3: Lobbyists' contacts with lawmakers and staff; fast (heuristic, relational) and slow (evidence) appeals; the tobacco playbook reused by other industries
  3. L5: The decision to lobby directly: transactional (money for access) or persuasion (information)

way out: Litigation and amicus briefs

  1. L1: Rulings that bind (school segregation ruled unconstitutional)
  2. L3: Funding cases; filing amicus curiae briefs
  3. L5: Choosing the courts as venue

way out: Members-only benefits

  1. L1: Members kept in (and dues kept coming)
  2. L2: Discounts, travel, meals, subscriptions; the sociability of membership
  3. L5: Deciding what to give members

way out: Outside (grassroots) lobbying and media campaigns

  1. L1: The public's views and the pressure they put on officials
  2. L3: Mobilising citizens by public relations, advertising and social media
  3. L5: The decision to go public: use outsider status for sympathy, or press an ideological agenda

way out: Protest, petition and direct action

  1. L1: Bodies in the street, signatures on the roll, purchases withheld
  2. L3: Marches, boycotts and petition drives (the 1791 sugar boycott, the 1806 petition drive)
  3. L5: Choosing protest: groups with fewer resources use direct action and civil disobedience

way out: Research, briefings and position papers

  1. L1: What policymakers know and say: specialised knowledge as a legislative subsidy
  2. L4: Position papers, research and briefings (texts that MEPs' speeches come to echo)
  3. L6: The cause put as evidence and argument

Sources (28) published science

Political party (Wikipedia, via Wikimedia Enterprise snapshot 2026-11-01)
Advocacy group (Wikipedia, via Wikimedia Enterprise)
Huwyler, Turner-Zwinkels & Bailer 2023, No Representation Without Compensation: The Effect of Interest Groups on Legislators' Policy Area Focus, Political Research Quarterly 76(3):1388-, doi:10.1177/10659129221137035 (PMC10415157) (behind its links)
Iron triangle (US politics) (Wikipedia, via Wikimedia Enterprise) (behind its links)
Pluralism (political theory) (Wikipedia, via Wikimedia Enterprise) (behind its links)
Langtry 2022, Inside the West Wing: Lobbying as a contest, arXiv:2207.00800 (behind its links)
Rozbicka & Mahrenbach 2023, Beyond the usual suspects: interest groups in the Global South, Interest Groups & Advocacy 12(2):115-131, doi:10.1057/s41309-023-00187-2 (PMC10034869) (behind its links)
Bitonti, Mugellini, Mariotti, Francoli & Villeneuve 2025, Citizens and the public perception of lobbying: do regulation and trust in political institutions make a difference?, Interest Groups & Advocacy 14(3):270-, doi:10.1057/s41309-025-00237-x (PMC12416409) (behind its links)
Lobbying (Wikipedia, via Wikimedia Enterprise) (behind its links)
Kim, Kim, Jeong, Oh & Kim 2025, Measuring Interest Group Positions on Legislation: An AI-Driven Analysis of Lobbying Reports, arXiv:2504.15333 (behind its links)
Bacik KA, Ondras J, Rudkin A, Dunkel J, Kim IS. 2025/2026. Measuring the dynamical evolution of the United States lobbying network. arXiv:2503.11745v2 (behind its links)
Lobbying in the United States (Wikipedia, via Wikimedia Enterprise) (behind its links)
Chung, Cullerton & Lacy-Nichols 2024, Mapping the Lobbying Footprint of Harmful Industries: 23 Years of Data From OpenSecrets, Milbank Quarterly 102(1):212-232, doi:10.1111/1468-0009.12686 (PMC10938928) (behind its links)
Lacy-Nichols, Baradar, Crosbie & Cullerton 2025, Lobbying in the Shadows: A Comparative Analysis of Government Lobbyist Registers, Milbank Quarterly 103(2):857-882, doi:10.1111/1468-0009.70033 (PMC12438441) (behind its links)
Kanter, Mankowitz et al. 2026, Prevalence of ties to industry-funded organizations among patient and consumer representatives on FDA advisory committees, Health Affairs Scholar 4(10):344-350, doi:10.1093/haschl/qxag269 (PMC13678205) (behind its links)
Rasmussen & Otjes 2024/2025, Responding to whom? An experimental study of the dynamics of responsiveness to interest groups and the public, Journal of European Public Policy 32(3):727-754, doi:10.1080/13501763.2024.2306226 (PMC11835311) (behind its links)
The Logic of Collective Action (Wikipedia, via Wikimedia Enterprise) (behind its links)
DiSalvo 2022, Interest groups, local politics, and police unions, Interest Groups & Advocacy 11(2):263-, doi:10.1057/s41309-021-00146-9 (PMC8783788) (behind its links)
Slobozhan I, Ormosi P, Sharma R. 2020. Which bills are lobbied? Predicting and interpreting lobbying activity in the US. arXiv:2005.06386 (behind its links)
De Bruycker 2025/2026, Lobbying, fast and slow: principles of influence beyond reason, Interest Groups & Advocacy 15(2):155-176, doi:10.1057/s41309-025-00255-9 (PMC13148985) (behind its links)
Regulatory capture (Wikipedia, via Wikimedia Enterprise) (behind its links)
Jaenecke & Lacy-Nichols 2026, Rethinking revolving door research: a scoping review of methods and datasets used by non-academics to examine the revolving door, Globalization and Health 22:11, doi:10.1186/s12992-025-01184-7 (PMC12896196) (behind its links)
Principal-agent problem (Wikipedia, via Wikimedia Enterprise snapshot) (behind its links)
Zhou 2023, The effects of lobbying on the FDA's recall classification, BMC Medical Ethics 24:41, doi:10.1186/s12910-023-00921-0 (PMC10280948) (behind its links)
Suresh, Radojevic, Salvi, Magron, Kristof & Grossglauser 2023, Studying Lobby Influence in the European Parliament, arXiv:2309.11381 (behind its links)
Jagers, Harring, Löfgren, Sjöstedt, Alpizar, Brülde, Langlet, Nilsson et al. 2020, On the preconditions for large-scale collective action, Ambio 49(7):1282-1296, doi:10.1007/s13280-019-01284-w (PMC7190586) (behind its links)
Lerch, Smith, Koffel, Bagby & Abbott 2022, How public can public goods be? Environmental context shapes the evolutionary ecology of partially private goods, PLoS Computational Biology 18(11):e1010666, doi:10.1371/journal.pcbi.1010666 (PMC9651594) (behind its links)
Lindsay, Holder, Hewlett & Gudelj 2024, Experimental evolution of yeast shows that public-goods upregulation can evolve despite challenges from exploitative non-producers, Nature Communications, doi:10.1038/s41467-024-52043-9 (PMC11379824) (behind its links)